CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. (Nasdaq: INFI) (“Infinity”), a clinical-stage biotechnology company developing eganelisib, a ...
– Infinity Previously Announced Definitive Merger Agreement with MEI Pharma to Advance Three Promising Clinical Oncology Candidates – CAMBRIDGE, Mass.--(BUSINESS WIRE)--Infinity Pharmaceuticals, Inc. ...
Infinity shares jump about 11% at open Oil & gas firm raises $265 mln in 2025's third energy IPO Buyout firms Pearl, NGP among Infinity's backers Jan 31 (Reuters) - Infinity Natural Resources (INR.N), ...
Infinity Property and Casualty Corp. (NASDAQ:IPCC) will have a new CEO next year. The Birmingham-headquartered insurance company's President, Chairman and CEO James Gober will retire in the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results